EUVIMEDEUVIMED entdecken
Multizentrische Studie

Mediastinal grey zone lymphomas: Results of the expert pathological review analysis of a case series enrolled in the multicentre BIOGZL ‐2020 study in Italy

Elena Sabattini iD, Stefano Ascani, Sabino Ciavarella iD, Arianna Di Napoli, Fabio Facchetti, Stefano Lazzi, Lorenzo Leoncini, Luisa Lorenzi, Marco Lucioni iD, Giovanna Motta iD, Luca Nassi, Alice Parisi und 6 weitere

British Journal of Haematology · 2026-06 · 208 (6) · 2016-2025

DOI: 10.1111/bjh.70432 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift British Journal of Haematology, online erschienen am 17.03.2026. Verfasst von Elena Sabattini und 17 weiteren Autor:innen. Beteiligte Einrichtung: Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Mediastinal Neoplasms. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Associazione Italiana Contro le Leucemie-Linfomi e Mieloma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mediastinal grey zone lymphoma (MGZL) is a rare disease with overlapping features between classical Hodgkin lymphoma (CHL) and primary mediastinal large B‐cell lymphoma (PMBL). The recent classifications limit the disease to mediastinal cases. Epstein–Barr virus (EBV) is negative in most instances. Predominant resemblance to CHL (MGZL‐HL) or primary mediastinal B‐cell lymphoma (MGZL‐PMBL) can commonly be defined, although mixed features do occur. The morpho‐phenotypic heterogeneity of MGZL has significantly affected diagnostic reproducibility also among experts and the proposed diagnostic criteria turned out less concrete than for other lymphomas. Seventy GZL cases were collected from 14 Italian centres and slides reviewed by expert haematopathologists: 17 samples were confirmed according to current classification criteria, the residual being reclassified, mostly as CHL and PMBL, which well reflects the diagnostic challenge. By applying six B‐cell markers, MGZL‐HL commonly expressed ≥4 B‐antigens in ≥50% neoplastic cells at moderate–strong intensity; MGZL‐PMBL expressed less B‐cell markers than expected (average 3.4 per case, in ≥50% neoplastic cells) at variable intensity. Overall, morphology, number of positive B‐cell markers, staining intensity and percentage of positive neoplastic cells are features that must be considered collectively, case by case, trying to adhere to the recent classification criteria, being aware that not all cases may easily be included.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mediastinal NeoplasmsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedBiomarkers, TumorHodgkin DiseaseItaly

Stichwörter der Autor:innen

B‐cell markersHodgkingrey zonelymphomamediastinal

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Anatomic Pathology Unit, Azienda S. Maria, University of Terni, Terni, Italy.
  • Hematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
  • Pathology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, Rome, Italy.
  • Pathology Unit, Department of Molecular and Translational Medicine-DMMT, University of Brescia, Brescia, Italy.
  • Anatomic Pathology Unit, Department of Medical Biotechnology, University of Siena, Siena, Italy.

ORCID-Profile: Elena Sabattini, Sabino Ciavarella, Marco Lucioni, Giovanna Motta

Förderung

  • Associazione Italiana Contro le Leucemie-Linfomi e Mieloma

Zitieren

APA

Sabattini, E., Ascani, S., Ciavarella, S., Di Napoli, A., Facchetti, F., Lazzi, S., Leoncini, L., Lorenzi, L., Lucioni, M., Motta, G., Nassi, L., Parisi, A., Paulli, M., Pileri, S., Ponzoni, M., Tripodo, C., Righi, S., & Agostinelli, C. (2026). Mediastinal grey zone lymphomas: Results of the expert pathological review analysis of a case series enrolled in the multicentre BIOGZL ‐2020 study in Italy. British Journal of Haematology, 208(6), 2016-2025. https://doi.org/10.1111/bjh.70432

Vancouver

Sabattini E, Ascani S, Ciavarella S, Di Napoli A, Facchetti F, Lazzi S, et al. Mediastinal grey zone lymphomas: Results of the expert pathological review analysis of a case series enrolled in the multicentre BIOGZL ‐2020 study in Italy. British Journal of Haematology. 2026;208(6):2016-2025. doi:10.1111/bjh.70432

BibTeX
@article{Sabattini2026,
  author = {Sabattini, Elena and Ascani, Stefano and Ciavarella, Sabino and Di Napoli, Arianna and Facchetti, Fabio and Lazzi, Stefano and Leoncini, Lorenzo and Lorenzi, Luisa and Lucioni, Marco and Motta, Giovanna and Nassi, Luca and Parisi, Alice and Paulli, Marco and Pileri, Stefano and Ponzoni, Maurilio and Tripodo, Claudio and Righi, Simona and Agostinelli, Claudio},
  title = {Mediastinal grey zone lymphomas: Results of the expert pathological review analysis of a case series enrolled in the multicentre BIOGZL ‐2020 study in Italy},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {208},
  number = {6},
  pages = {2016--2025},
  doi = {10.1111/bjh.70432}
}
Kostenlos starten →